| Anaemia | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG00021 events14 affected95 at risk
- EG0010 affected33 at risk
|
| Blood loss anaemia | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0005 events5 affected95 at risk
- EG0010 affected33 at risk
|
| Disseminated intravascular coagulation | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Normocytic anaemia | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0007 events7 affected95 at risk
- EG0010 affected33 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arrhythmic storm | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00013 events12 affected95 at risk
- EG0010 affected33 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00011 events11 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00028 events16 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00012 events9 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00037 events24 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac perforation | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac pseudoaneurysm | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac valve disease | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00012 events12 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Congestive cardiomyopathy | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Intracardiac thrombus | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Palpitations | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Pericardial haemorrhage | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events4 affected95 at risk
- EG0010 affected33 at risk
|
| Right ventricular dysfunction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Sinus node dysfunction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Ventricle rupture | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Ventricular dysfunction | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG0007 events6 affected95 at risk
- EG0010 affected33 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 25.0 | Systematic Assessment | | - EG00016 events12 affected95 at risk
- EG0010 affected33 at risk
|
| Left ventricle outflow tract obstruction | Congenital, familial and genetic disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pyloric stenosis | Congenital, familial and genetic disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Anorectal disorder | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Intra-abdominal haematoma | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Asthenia | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac death | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Chest pain | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Death | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Multi-organ disorder | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Multiple organ dysfunction syndrome | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Pain | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Physical deconditioning | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Prosthetic cardiac valve stenosis | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Prosthetic cardiac valve thrombosis | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pyrexia | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Sudden cardiac death | General disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cholestasis | Hepatobiliary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Hypertransaminasaemia | Hepatobiliary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Appendicitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arthritis infective | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Bacteriuria | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Biliary sepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Bronchitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Bursitis infective | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| COVID-19 | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| COVID-19 pneumonia | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cellulitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0006 events4 affected95 at risk
- EG0010 affected33 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Clostridium difficile infection | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cystitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Endocarditis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Endocarditis bacterial | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Endocarditis staphylococcal | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Epididymitis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Escherichia bacteraemia | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Gastroenteritis norovirus | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Influenza | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0004 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Myocardiac abscess | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Perineal abscess | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pneumonia | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG00019 events14 affected95 at risk
- EG0010 affected33 at risk
|
| Pneumonia aspiration | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Pneumonia serratia | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pulmonary sepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Sepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0004 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Septic shock | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0004 events4 affected95 at risk
- EG0010 affected33 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG00011 events8 affected95 at risk
- EG0010 affected33 at risk
|
| Urinary tract infection pseudomonal | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Urosepsis | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Wound infection | Infections and infestations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Accidental overdose | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Coronary vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0005 events5 affected95 at risk
- EG0010 affected33 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Ilium fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Incision site haematoma | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Mechanical ventilation complication | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Postoperative delirium | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0006 events6 affected95 at risk
- EG0010 affected33 at risk
|
| Tracheal haemorrhage | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Urinary retention postoperative | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Vasoplegia syndrome | Injury, poisoning and procedural complications | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Anticoagulation drug level above therapeutic | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Blood creatinine increased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cardiac output decreased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Ejection fraction decreased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Electrocardiogram QRS complex prolonged | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Heart rate increased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Staphylococcus test positive | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| White blood cell count increased | Investigations | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Hyperuricaemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Hypervolaemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0005 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Iron deficiency | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Groin pain | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Osteitis deformans | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Adenocarcinoma gastric | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Diffuse large B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Plasma cell myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0007 events7 affected95 at risk
- EG0010 affected33 at risk
|
| Cerebrovascular disorder | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Embolic stroke | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Intensive care unit acquired weakness | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Seizure like phenomena | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Syncope | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events4 affected95 at risk
- EG0010 affected33 at risk
|
| Device breakage | Product Issues | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Device dislocation | Product Issues | MedDRA 25.0 | Systematic Assessment | | - EG0005 events5 affected95 at risk
- EG0010 affected33 at risk
|
| Prosthetic cardiac valve malfunction | Product Issues | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Delirium | Psychiatric disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG00011 events11 affected95 at risk
- EG0010 affected33 at risk
|
| Bladder outlet obstruction | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cystitis haemorrhagic | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0007 events7 affected95 at risk
- EG0010 affected33 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Ureterolithiasis | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Urethral caruncle | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0004 events4 affected95 at risk
- EG0010 affected33 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0009 events8 affected95 at risk
- EG0010 affected33 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG00013 events11 affected95 at risk
- EG0010 affected33 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Respiratory depression | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG00013 events13 affected95 at risk
- EG0010 affected33 at risk
|
| Tachypnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Cholecystectomy | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Drug therapy | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Endotracheal intubation | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Exploratory operation | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Mechanical ventilation | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Renal replacement therapy | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Toe amputation | Surgical and medical procedures | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arterial disorder | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Arterial perforation | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Haematoma | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Haemodynamic instability | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Haemorrhage | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0003 events3 affected95 at risk
- EG0010 affected33 at risk
|
| Hypotension | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0006 events6 affected95 at risk
- EG0010 affected33 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Peripheral artery occlusion | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Peripheral artery stenosis | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0002 events2 affected95 at risk
- EG0010 affected33 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 25.0 | Systematic Assessment | | - EG0001 events1 affected95 at risk
- EG0010 affected33 at risk
|
| Anaemia | Blood and lymphatic system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Blood loss anaemia | Blood and lymphatic system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Haemolytic anaemia | Blood and lymphatic system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acquired left ventricle outflow tract obstruction | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG00118 events7 affected33 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events3 affected33 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events4 affected33 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0018 events7 affected33 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG00110 events8 affected33 at risk
|
| Cardiac pseudoaneurysm | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Chronic left ventricular failure | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cor pulmonale | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Systolic dysfunction | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Ventricular dyssynchrony | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cataract | Eye disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0015 events4 affected33 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Pharyngo-oesophageal diverticulum | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Pneumoperitoneum | Gastrointestinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Chest pain | General disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Prosthetic cardiac valve stenosis | General disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Prosthetic cardiac valve thrombosis | General disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Liver injury | Hepatobiliary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acute endocarditis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| COVID-19 | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Cellulitis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Endocarditis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Escherichia bacteraemia | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Fungal peritonitis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Infected dermal cyst | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Peritonitis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Pneumonia | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Pneumonia aspiration | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Prosthetic valve endocarditis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Pulmonary sepsis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Sepsis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events3 affected33 at risk
|
| Septic shock | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Staphylococcal bacteraemia | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events2 affected33 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0018 events8 affected33 at risk
|
| Cardiac procedure complication | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Corneal abrasion | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events4 affected33 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Periorbital haematoma | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Post procedural hypotension | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events4 affected33 at risk
|
| Transfusion reaction | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Vascular access site haematoma | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events3 affected33 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Vasoplegia syndrome | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Anticoagulation drug level above therapeutic | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Anticoagulation drug level below therapeutic | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Ejection fraction decreased | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Electrocardiogram ST segment elevation | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| International normalised ratio increased | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Pulse absent | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Transvalvular pressure gradient increased | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Troponin increased | Investigations | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hypervolaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events1 affected33 at risk
|
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cerebellar haemorrhage | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events2 affected33 at risk
|
| Dementia | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Dysarthria | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Seizure | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Seizure like phenomena | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Syncope | Nervous system disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Device dislocation | Product Issues | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Prosthetic cardiac valve malfunction | Product Issues | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Alcohol withdrawal syndrome | Psychiatric disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG00110 events8 affected33 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events2 affected33 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events3 affected33 at risk
|
| Nephropathy toxic | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Polyuria | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0013 events3 affected33 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events2 affected33 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Medical device implantation | Surgical and medical procedures | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Air embolism | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0012 events2 affected33 at risk
|
| Hypertension | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Hypotension | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0014 events4 affected33 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|
| Shock | Vascular disorders | MedDRA 26.0 | Systematic Assessment | | - EG0000 affected95 at risk
- EG0011 events1 affected33 at risk
|